Consisting of five separate booklets, the World Drug Report 2022 provides an in-depth analysis of global drug markets and examines the nexus between drugs and the environment within the bigger picture of the Sustainable Development Goals, climate change and environmental sustainability.

Booklet 1 - Executive Summary / Policy implications - Booklet 1 summarizes the four subsequent booklets by reviewing their key findings and highlighting their policy implications.  

Booklet 2 - Global overview of drug demand and drug supply - Constituting the second part of the World Drug Report 2022, the booklet 2 contains an overview of the global demand for and supply of drugs. 

Booklet 3 - Drug market trends: Opioids, Cannabis - Constituting the third part of the World Drug Report 2022, the booklet 3 contains an analysis of the global market for cannabis, starting with a review of cannabis supply, including trends in the cultivation of and trafficking in cannabis herb and cannabis resin at the global level and in the various regions. With respect to opioids, the booklet discusses the overlaps between the various opioids, mostly in terms of demand dynamics. It also contains the latest estimates of and trends in opioid use at the global and regional levels. 

Booklet 4 - Drug market trends: Cocaine, Amphetamine-type stimulants - Constituting the fourth part of the World Drug Report 2022, the booklet 4 contains an analysis of the global market for cocaine, starting with a review of cocaine supply, including trends in the cultivation of coca bush and in the manufacture of and trafficking in cocaine at the global level and in the various regions. It also contains an overview of the latest estimates of and trends in cocaine use in different markets. 

Booklet 5 - Drugs and the environment- Constituting the fifth part of the World Drug Report 2022, booklet 5 contains a deep dive into the nexus between drugs and the environment. The aim is to provide a comprehensive overview of the current state of research into the direct and indirect effects of illicit crop cultivation, drug manufacture and drug policy responses on the environment, in order to assist Member States in anticipating and addressing environmental challenges and in mitigating risks.